Scientists have pioneered a breakthrough in food safety by developing gene-edited wheat that significantly reduces the carcinogenic risks associated with toasted bread. Researchers at Rothamsted Research in Harpenden, Hertfordshire, employed Crispr genome editing technology to modify wheat DNA, targeting the production of free asparagine, an amino acid that converts into acrylamide during baking, frying, or toasting.
Understanding the Acrylamide Risk
Acrylamide is a toxic compound classified as a probable carcinogen by scientists. It forms when free asparagine in wheat undergoes chemical changes during high-temperature cooking processes. This has raised health concerns globally, particularly for staple foods like bread and biscuits.
Crispr Technology in Action
The Crispr method allows for precise edits to the wheat genome, specifically targeting genes responsible for asparagine synthesis. In field trials spanning two years, the edited wheat lines demonstrated a remarkable reduction in free asparagine levels—by 59% in single-edited lines and up to 93% in dual-edited variants—without any negative impact on crop yields.
In contrast, conventional mutation techniques, which rely on chemical agents to induce random genetic changes, achieved only a 50% reduction in asparagine but incurred a nearly 25% yield penalty due to unintended mutations elsewhere in the genome.
Implications for Food Production
Bread and biscuits made from the Crispr-edited wheat showed substantially lower acrylamide concentrations. Some bread samples even had acrylamide levels falling below detectable limits after toasting, highlighting the potential for safer food products.
Dr Navneet Kaur, a lead researcher at Rothamsted, emphasized the significance of this advancement: "This work demonstrates the power of Crispr technology to deliver precise, beneficial changes in crop genetics. With supportive regulatory frameworks, we can unlock significant benefits for agriculture and food systems."
Regulatory Landscape and Challenges
Since Brexit, the UK has emerged as a global hub for gene editing research, facilitated by the Genetic Technology (Precision Breeding) Act of 2023, which eases restrictions on genetically modified crops. However, ongoing negotiations with the EU over sanitary and phytosanitary agreements could threaten this progress if dynamic alignment with EU food rules is enforced without exemptions for precision-bred crops.
Simultaneously, the EU is tightening regulations on acrylamide, with plans to further restrict maximum levels in food this year. This could impact exports, including from the UK, where high-acrylamide products might face bans.
Future Prospects and Consumer Safety
Professor Nigel Halford, who led the study, noted the broader implications: "Low-acrylamide wheat could enable food businesses to meet evolving safety standards without compromising product quality or incurring major production costs. It also offers a meaningful opportunity to reduce the dietary exposure of consumers to acrylamide."
This innovation not only addresses public health concerns but also aligns with sustainable agricultural practices, potentially transforming food safety protocols worldwide. As regulatory discussions continue, the adoption of such technologies could pave the way for healthier diets and more resilient food systems.
